Therefore, we believe that Mstn is a promising target for inhibiting skeletal muscle proliferation and activating muscular atrophy, and Mstn gene knockout may effectively reduce the loss of skeletal muscle mass in sarcopenia. This evidence concerns the gene MSTN and sarcopenia.